W.K. Evans
Impact in
- Oncology top 10%
- Colorectal Cancer Treatments and Studies
- Lung Cancer Research Studies
-
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
- Gastric Cancer Management and Outcomes
Papers in ⓘ
- Oncology 14
- Lung Cancer Research Studies 6
-
- Lung Cancer Treatments and Mutations 11
- Lung Cancer Diagnosis and Treatment 5
- Co-authors
- Joseph L. Pater (3 shared papers)R. Feld (4 shared papers)Pamela J. Goodwin (1 shared paper)Ian D. Graham (2 shared papers)George P. Browman (2 shared papers)F. Shepherd (3 shared papers)Kathleen I. Pritchard (1 shared paper)D. Ian Hodson (1 shared paper)
- Journals
- Journal of Clinical Oncology (7 papers)European Journal of Cancer (4 papers)Journal of Thoracic Oncology (3 papers)Lung Cancer (3 papers)JNCI Journal of the National Cancer Institute (1 paper)
- Partner nations
- CanadaUnited StatesAustralia
In The Last Decade
W.K. Evans
30 papers receiving 501 citations
Peers
Comparison fields: 5 of 61
- Oncology 253
- Pulmonary and Respiratory Medicine 200
- Economics and Econometrics 160
- Public Health, Environmental and Occupational Health 99
- Cancer Research 49
Countries citing papers authored by W.K. Evans
This map shows the geographic impact of W.K. Evans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W.K. Evans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W.K. Evans more than expected).
Fields of papers citing papers by W.K. Evans
This network shows the impact of papers produced by W.K. Evans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W.K. Evans. The network helps show where W.K. Evans may publish in the future.
Co-authors
The 25 scholars most cited alongside W.K. Evans, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 122 | |
| 2 | 1998 | 104 | |
| 3 | 1988 | 77 | |
| 4 | 1985 | 35 | |
| 5 | 2000 | 34 | |
| 6 | The cost of managing lung cancer in Canada. | 1995 | 28 |
| 7 | Cost-effectiveness of gemcitabine in stage IV non-small cell lung cancer: an estimate using the Population Health Model lung cancer module. | 1997 | 27 |
| 8 | 2001 | 14 | |
| 9 | 1999 | 12 | |
| 10 | Ifosfamide, cisplatin, and etoposide (ICE) in the treatment of advanced non-small cell lung cancer. | 1992 | 10 |
| 11 | Chemotherapy for relapsed small cell lung cancer: a clinical practice guideline | 2006 | 8 |
| 12 | 2000 | 8 | |
| 13 | A model for estimating the costs and burdens of breast cancer diagnosis and treatment in Canada. | 1993 | 8 |
| 14 | Use of vinorelbine in non-small-cell lung cancer | 1997 | 7 |
| 15 | Use of vinorelbine in non-small-cell lung cancer. Provincial Lung Disease Site Group. | 1997 | 7 |
| 16 | 2008 | 6 | |
| 17 | Second-line or subsequent systemic therapy for recurrent or progressive non-small cell lung cancer: a clinical practice guideline | 2006 | 6 |
| 18 | The use of chemotherapy in patients with advanced malignant pleural mesothelioma: a clinical practice guideline | 2012 | 4 |
| 19 | 2004 | 3 | |
| 20 | Use of the epidermal growth factor receptor inhibitors gefitinib and erlotinib in the treatment of non-small cell lung cancer: a clinical practice guideline | 2006 | 3 |
About W.K. Evans
W.K. Evans is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Family Practice, Economics and Econometrics and Cancer Research, having authored 31 papers that have together received 538 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (11 papers), Economic and Financial Impacts of Cancer (8 papers), Lung Cancer Research Studies (6 papers), Health Systems, Economic Evaluations, Quality of Life (6 papers), Lung Cancer Diagnosis and Treatment (5 papers), Clinical practice guidelines implementation (4 papers), Advances in Oncology and Radiotherapy (3 papers) and Palliative Care and End-of-Life Issues (3 papers). The work is most often cited by research in Oncology (253 citations), Pulmonary and Respiratory Medicine (200 citations), Economics and Econometrics (160 citations), Public Health, Environmental and Occupational Health (99 citations) and Cancer Research (49 citations). W.K. Evans has collaborated with scholars based in Canada, United States and Australia. Frequent co-authors include Joseph L. Pater, R. Feld, Pamela J. Goodwin, Ian D. Graham, George P. Browman, F. Shepherd, Kathleen I. Pritchard, D. Ian Hodson, E. Ann Mohide and Derek J. Jonker. Their work appears in journals such as Journal of Clinical Oncology, European Journal of Cancer, Journal of Thoracic Oncology, Lung Cancer and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.